In Reference to How to Reduce the Risk of Adverse Events After COVID-19 Nasopharyngeal Swab

被引：1
|
作者：
Piazza, Fabio [1 ]
机构：
[1] ASST Carlo Poma Mantova, Dept Otolaryngol Head & Neck Surg, Str Lago Paiolo 10, I-46100 Mantua, Italy
来源：
LARYNGOSCOPE | 2021年 / 131卷 / 10期
关键词：
D O I：
10.1002/lary.29775
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：E2639 / E2639
页数：1
相关论文
共 50 条
  • [41] 3D-printed simulator for nasopharyngeal swab collection for COVID-19
    Koch, A.
    Vermel, M.
    Hansmann, Y.
    Lodi, M.
    Mura, C.
    Sananes, A.
    Gallien, S.
    Wurtz, E.
    Bleibtreu, A.
    Martinot, M.
    Exinger, J.
    Lescure, X.
    Kerneis, S.
    Lacombe, K.
    Mootien, J. Y.
    Shawali, C.
    Lecointre, L.
    Debry, C.
    Lefebvre, N.
    Sananes, N.
    INFECTIOUS DISEASES NOW, 2022, 52 (03): : 138 - 144
  • [42] Signaling COVID-19 Vaccine Adverse Events
    Rave Harpaz
    William DuMouchel
    Robbert Van Manen
    Alexander Nip
    Steve Bright
    Ana Szarfman
    Joseph Tonning
    Magnus Lerch
    Drug Safety, 2022, 45 : 765 - 780
  • [43] A 3D-printed nasopharyngeal swab for COVID-19 diagnostic testing
    Jonathan Ford
    Todd Goldstein
    Sean Trahan
    Allison Neuwirth
    Kyle Tatoris
    Summer Decker
    3D Printing in Medicine, 6
  • [44] Signaling COVID-19 Vaccine Adverse Events
    Harpaz, Rave
    DuMouchel, William
    Van Manen, Robbert
    Nip, Alexander
    Bright, Steve
    Szarfman, Ana
    Tonning, Joseph
    Lerch, Magnus
    DRUG SAFETY, 2022, 45 (07) : 765 - 780
  • [45] 3D-printed simulator for nasopharyngeal swab collection for COVID-19
    Sananes, Nicolas
    Lodi, Massimo
    Koch, Antoine
    Lecointre, Lise
    Sananes, Axel
    Lefebvre, Nicolas
    Debry, Christian
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2021, 278 (07) : 2649 - 2651
  • [46] Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19
    Tran, Huong N. Q.
    Risk, Malcolm
    Nair, Girish B.
    Zhao, Lili
    NPJ VACCINES, 2024, 9 (01)
  • [47] Risk of Neurologic or Immune-Mediated Adverse Events After COVID-19 Diagnosis in the United States
    Layton, J. Bradley
    Muthuri, Stella G.
    Lindaas, Arnstein
    Lloyd, Patricia C.
    Richey, Morgan M.
    Gruber, Joann F.
    Clarke, Tainya C.
    Kowarski, Lisa
    McKillop, Mollie
    Fisher, Shelby
    Lyu, Hai
    Cheng, Angela
    Bui, Christine L.
    Duenas, Pablo Freyria
    Chen, Yangping
    Forshee, Richard A.
    Anderson, Steven A.
    Beers, Jeffrey B.
    Burrell, Timothy
    Chillarige, Yoganand
    Anthony, Mary S.
    Shoaibi, Azadeh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 110 - 110
  • [48] OVERVIEW OF COVID-19 VACCINE ADVERSE EVENTS
    Dobrek, Lukasz
    ACTA POLONIAE PHARMACEUTICA, 2024, 81 (04): : 577 - 601
  • [49] Meningoencephalitis Secondary To Cerebrospinal Fluid Leakage From Nasopharyngeal COVID-19 Swab
    Alnafisah, Mohammed
    Altwairqi, Abdulrahman
    NEUROLOGY, 2023, 100 (17)
  • [50] Prospective Comparison of Saliva and Nasopharyngeal Swab Sampling for Mass Screening for COVID-19
    Nacher, Mathieu
    Mergeay-Fabre, Mayka
    Blanchet, Denis
    Benoit, Orelie
    Pozl, Tristan
    Mesphoule, Pauline
    Sainte-Rose, Vincent
    Vialette, Veronique
    Toulet, Bruno
    Moua, Aurelie
    Saout, Mona
    Simon, Stephane
    Guidarelli, Manon
    Galindo, Muriel
    Biche, Barbara
    Faurous, William
    Chaizemartin, Laurie
    Fahrasmane, Aniza
    Rochemont, Devi
    Vignier, Nicolas
    Vabret, Astrid
    Demar, Magalie
    FRONTIERS IN MEDICINE, 2021, 8
12345